✦ LIBER ✦

A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma

✍ Scribed by Khorana, Alok A; Rosenblatt, J D; Sahasrabudhe, D M; Evans, T; Ladrigan, M; Marquis, D; Rosell, K; Whiteside, T; Phillippe, S; Acres, B

Book ID: 110018983
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 197 KB
Volume: 10
Category: Article
ISSN: 0929-1903
DOI: 10.1038/sj.cgt.7700568

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of interferon-γ (IFN-γ) re

Phase I trial of interferon-γ (IFN-γ) retroviral vector administered intratumorally to patients with metastatic melanoma

✍ Nemunaitis, John; Fong, Timothy; Robbins, Joan M; Edelman, Gerald; Edwards, Wils 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 435 KB

A phase I trial of recombinant gamma int

A phase I trial of recombinant gamma interferon in patients with cancer

✍ Kenneth A. Foon; Stephen A. Sherwin; Paul G. Abrams; Henry C. Stevenson; Pamela 📂 Article 📅 1985 🏛 Springer-Verlag 🌐 English ⚖ 461 KB

Clinical phase II trial of recombinant d

Clinical phase II trial of recombinant dna interferon (interferon alfa 2b) in patients with metastatic malignant melanoma

✍ Thierry Dorval; Thao Palangie; Michel Jouve; Emilio Garcia-Giralt; Lucien Israel 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 3 views

Phase II trial of fotemustine in patient

Phase II trial of fotemustine in patients with metastatic malignant melanoma

✍ Carla I. Falkson; Geoffrey Falkson; Hendré C. Falkson 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 318 KB

A phase I-II trial of the combination of

A phase I-II trial of the combination of recombinant leukocyte a interferon and recombinant human interferon-γ in patients with metastatic malignant melanoma

✍ Edward T. Creagan; Charles L. Loprinzi; David L. Ahmann; Daniel J. Schaid 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

A phase I trial of α-interferon in combi

A phase I trial of α-interferon in combination with pentostatin in hematologic malignancies

✍ Bernard, Stephen ;Gill, Parkash ;Rosen, Peter ;Gavigan, Molly ;Steagall, Ann ;El 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 721 KB

Pentostatin, a novel inhibitor of adenosine deaminase, has shown activity in various lymphoid malignancies of both the T and B cell lineage. This agent has unique side effects and in general myelosuppression has been mild. Interferon has both antiviral and antineoplastic properties. This agent has s